This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Enteris Biopharma, Inc., Park Therapeutics, Inc., Taurus Development Company LLC. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022-2024
Title: Innovations of George R Maurer
Introduction
George R Maurer is a notable inventor based in Bell Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral delivery systems for calcitonin. With a total of 2 patents to his name, Maurer's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Maurer's latest patents focus on room temperature stable oral calcitonin formulations. These patents disclose room-temperature stable dosage forms for oral delivery of calcitonin, which are crucial for ensuring the efficacy of the medication. The formulations also include low water content dosage forms, which enhance stability and shelf life. Furthermore, the patents outline methods for producing these stable dosage forms and detail treatment methods that involve their administration.
Career Highlights
Throughout his career, George R Maurer has worked with several companies, including Enteris Biopharma, Inc. and Taurus Development Company LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the advancement of drug delivery systems.
Collaborations
Maurer has collaborated with notable professionals in the field, including James P Gilligan and Aniruddha M Railkar. These collaborations have likely enriched his work and expanded the scope of his inventions.
Conclusion
George R Maurer's contributions to the field of pharmaceuticals, particularly through his innovative patents, demonstrate his commitment to improving drug delivery systems. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile